Accordingly, CDR1as was found to promote tumor proliferation in nasopharyngeal carcinoma, colorectal cancer, non-small-cell lung cancer, osteosarcoma, laryngeal squamous cell carcinoma, gastric cancer and esophageal squamous cell carcinoma, respectively (Tang et al., 2017; Yang X. et al., 2017; Li R. C. et al., 2018; Pan et al., 2018; Xu et al., 2018; Zhang J. et al., 2018; Zhang X. et al., 2018; Huang et al., 2019; Zhong et al., 2019; Yang et al., 2020). This evidence concerns the gene LINC00632 and neoplasm.